Article info
Ovarian Cancer
The Prognostic Impact of the Pathological Response to Neoadjuvant Dose-Dense Therapy for Ovarian Carcinoma
- Address correspondence and reprint requests to Mayu Yunokawa, MD, PhD, Department of Breast and Medical Oncology, National Cancer Center Hospital 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104–0045, Japan. E-mail: myunokaw{at}ncc.go.jp.
Citation
The Prognostic Impact of the Pathological Response to Neoadjuvant Dose-Dense Therapy for Ovarian Carcinoma
Publication history
- Received May 8, 2017
- Accepted July 17, 2017
- First published November 1, 2017.
Online issue publication
February 27, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2017 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.